2.98Open5.07Pre Close3 Volume240 Open Interest48.00Strike Price985.00Turnover70.27%IV-1.27%PremiumDec 20, 2024Expiry Date3.76Intrinsic Value100Multiplier4DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type-0.8657Delta0.0694Gamma11.20Leverage Ratio-0.0834Theta-0.0036Rho-9.70Eff Leverage0.0097Vega
CRISPR Therapeutics Stock Discussion
-TSLA
-PLTR
-SQ
were sold out in the last 10 days.
But, the institution also bought back some of
+COIN
+Amazon
+ILMN
+Meta
at lower price.
But on Nov 6, they bought back 1 Billion worth of TSLA at +/- 281 $ and 468 Million worth of PLTR stock at +/- 55$ back in their portfolio...
(Probably FOMO for PLTR or ...
Most of Wallstreet and retail investors don't understand Crispr and most see it as a very risky stock to invest in but once it begins rolling out its cures and making obscene amounts of cash..Along with license agreements to other companies Crispr Theraputics share price will rise significantly. ...
No comment yet